Pierpaolo Pellicori1, Jufen Zhang2, Elena Lukaschuk2, Anil C Joseph2, Christos V Bourantas2, Huan Loh2, Thanjavur Bragadeesh2, Andrew L Clark2, John G F Cleland3. 1. Department of Cardiology, Castle Hill Hospital, Hull York Medical School (at University of Hull), Kingston Upon Hull HU16 5JQ, UK pierpaolo.pellicori@hey.nhs.uk p.pel@libero.it. 2. Department of Cardiology, Castle Hill Hospital, Hull York Medical School (at University of Hull), Kingston Upon Hull HU16 5JQ, UK. 3. Department of Cardiology, Castle Hill Hospital, Hull York Medical School (at University of Hull), Kingston Upon Hull HU16 5JQ, UK National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, UK.
Abstract
BACKGROUND: Left atrial (LA) volume is an important marker of cardiac dysfunction and cardiovascular outcome in heart failure (HF), but LA function is rarely measured. METHODS: Left atrial emptying function (LAEF), its clinical associations and prognostic value was studied in outpatients referred with suspected HF who were in sinus rhythm and had cardiac magnetic resonance imaging (CMRI). Heart failure was defined as relevant symptoms and signs with either a left ventricular ejection fraction (LVEF) <50% or amino-terminal pro-B-type natriuretic peptide (NTproBNP) >400 pg/mL (or >125 pg/mL if taking loop diuretics). RESULTS: Of 982 patients, 664 fulfilled the HF criteria and were in sinus rhythm. The median (interquartile range, IQR) LAEF was 42 (31-51)% and 55 (48-61)% in patients with and without HF (P < 0.001). Patients with HF in the lowest quartile of LAEF (23%; IQR: 17-28%) had lower LV and right ventricular (RV) EF, and greater LV and RV mass and higher plasma NTproBNP than those in the highest quartile of LAEF (56%; IQR: 53-61%). Log[LAEF] and log[NTproBNP] were inversely correlated (r = -0.410, P < 0.001). During a median follow-up of 883 (IQR: 469-1626) days, 394 (59%) patients with HF died or were admitted with HF and 101 (15%) developed atrial fibrillation (AF). In a multivariable Cox model, increasing LAEF, but not LVEF, was independently associated with survival (HR for 10% change: 0.81 (95%CI: 0.73-0.90), P = <0.001). Increasing age and decreasing LAEF predicted incident AF. CONCLUSIONS: In patients with HF, LAEF predicts adverse outcome independently of other measures of cardiac dysfunction. Published on behalf of the European Society of Cardiology. All rights reserved.
BACKGROUND: Left atrial (LA) volume is an important marker of cardiac dysfunction and cardiovascular outcome in heart failure (HF), but LA function is rarely measured. METHODS: Left atrial emptying function (LAEF), its clinical associations and prognostic value was studied in outpatients referred with suspected HF who were in sinus rhythm and had cardiac magnetic resonance imaging (CMRI). Heart failure was defined as relevant symptoms and signs with either a left ventricular ejection fraction (LVEF) <50% or amino-terminal pro-B-type natriuretic peptide (NTproBNP) >400 pg/mL (or >125 pg/mL if taking loop diuretics). RESULTS: Of 982 patients, 664 fulfilled the HF criteria and were in sinus rhythm. The median (interquartile range, IQR) LAEF was 42 (31-51)% and 55 (48-61)% in patients with and without HF (P < 0.001). Patients with HF in the lowest quartile of LAEF (23%; IQR: 17-28%) had lower LV and right ventricular (RV) EF, and greater LV and RV mass and higher plasma NTproBNP than those in the highest quartile of LAEF (56%; IQR: 53-61%). Log[LAEF] and log[NTproBNP] were inversely correlated (r = -0.410, P < 0.001). During a median follow-up of 883 (IQR: 469-1626) days, 394 (59%) patients with HF died or were admitted with HF and 101 (15%) developed atrial fibrillation (AF). In a multivariable Cox model, increasing LAEF, but not LVEF, was independently associated with survival (HR for 10% change: 0.81 (95%CI: 0.73-0.90), P = <0.001). Increasing age and decreasing LAEF predicted incident AF. CONCLUSIONS: In patients with HF, LAEF predicts adverse outcome independently of other measures of cardiac dysfunction. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Inna Y Gong; Payam Yazdan-Ashoori; Laura Jimenez-Juan; Nigel S Tan; Paul Angaran; Binita Riya Chacko; Saif Al-Mousawy; Sheldon M Singh; Tamar Shalmon; Luciano Folador; Iqwal Mangat; Djeven P Deva; Andrew T Yan Journal: Int J Cardiovasc Imaging Date: 2021-03-01 Impact factor: 2.357
Authors: Felix Hohendanner; F R Heinzel; F Blaschke; B M Pieske; W Haverkamp; H L Boldt; A S Parwani Journal: Heart Fail Rev Date: 2018-01 Impact factor: 4.214
Authors: Alexandra Gonçalves; Chung-Lieh Hung; Brian Claggett; Kotaro Nochioka; Susan Cheng; Dalane W Kitzman; Amil M Shah; Scott D Solomon Journal: Circ Cardiovasc Imaging Date: 2016-02 Impact factor: 7.792